Antitumoral activity of acadesine and rituximab in MCL

GSE47871

Homo sapiens

12 Downloadable Samples

Affymetrix Human Genome U219 Array (hgu219)

Submitter Supplied Information

Description

Acadesine is a nucleoside analogue with known antileukemic effects in different neoplasms. We investigated the activity of acadesine ne exerts a cytotoxic effect in MCL and synergizes with rituximab supporting clinical examination of this strategy for MCL patients

PubMed ID

24519895

Publication Title

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma.

Total Samples

Submitter’s Institution

IDIBAPS-HOSPITAL CLINIC

Authors

Montraveta A, Xargay-Torrent S, López-Guerra M, Rosich L, Pérez-Galán P, Salaverria I, Beà S, Kalko SG, de Frias M, Campàs C, Roué G, Colomer D

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-47871

No rows found